2025 H2 -tulosraportti
32 päivää sitten
‧38 min
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 1 155 | - | - | ||
| 1 559 | - | - | ||
| 3 022 | - | - | ||
| 3 719 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·3 min sittenChoose to interpret it as a good sign; Thor Medical is looking for a Laboratory Engineer/Laboratory Technician https://www.finn.no/457414338
·20 min sittenhttps://investorprat.com/TRMED/short The short was increased by 400k more shares, they are now short 2228k shares!
·13 min sittenThere might be a rally again soon. A bit early at mechanical completion, but perhaps when news about actual products being sent out to customers. After the common holiday period, that news can come at any time. Then it is reasonable to assume that the share price will go up. Will be very disappointed if the share price only stabilizes around 5kr then. Allowed to hope for a doubling by New Year. Then the short sellers will be annoyed
·5 t sittenI was wrong when I said I thought Arctic would come with a price target right after Q4, but now I am even more certain that an updated analysis is just around the corner. Why? Because so much fundamentally has strengthened, both in terms of customers, the factory, the annual report running smoothly, a conference in China where one can price in the possibility of partnerships and/or investors willing to pay up for such groundbreaking technology. In the previous analysis, I believe they priced in a lot of risk, in terms of things that could go wrong up until today, and that is certainly the case now.. the only thing missing now is the completed factory, but I believe it's as good as finished, especially when the picture of Jasper Kurth on linkedin is of a specific slide stating that it is on schedule. Then there's DNB's analysis, probably the most conservative analysis on the Oslo Stock Exchange. Yes, it was thoroughly analyzed, but they only emphasized risk, not tax loss carryforward, and minimal value in terms of sales and customers. Personally, I'm guessing a price target of 6.5 from Arctic. What do you think?- 10 t sitten10 t sittenhttps://www.linkedin.com/posts/thor-medical-asa_cancertreatment-precisionmedicine-radiopharmaceuticals-activity-7444272483211366400-kwT2?utm_source=share&utm_medium=member_ios&rcm=ACoAADUVyGgBbKFcdpxXInSkiOE2XLD9nnPl2WY Back from a good trip to Chengdu, China, and the XDC conference where our CEO, Jasper C. Kurth, presented Thor Medical and the growing interest in lead-212 and our role in the Targeted Alpha Therapy (TAT) landscape. It was great to meet so many talented professionals in the field of radiopharmaceuticals. Thank you for hosting, C-Ray Therapeutics! #CancerTreatment #PrecisionMedicine #Radiopharmaceuticals #AlphaTherapy·8 t sittenIf one looks at one of his slides, it clearly states that completion is on schedule for April. I believe that the most difficult part with the factory is done and that only the finishing touches and machine placements remain now.
- ·10 t sittenFantastic price to buy at for the long-term investor..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H2 -tulosraportti
32 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 min sittenChoose to interpret it as a good sign; Thor Medical is looking for a Laboratory Engineer/Laboratory Technician https://www.finn.no/457414338
- ·20 min sittenhttps://investorprat.com/TRMED/short The short was increased by 400k more shares, they are now short 2228k shares!·13 min sittenThere might be a rally again soon. A bit early at mechanical completion, but perhaps when news about actual products being sent out to customers. After the common holiday period, that news can come at any time. Then it is reasonable to assume that the share price will go up. Will be very disappointed if the share price only stabilizes around 5kr then. Allowed to hope for a doubling by New Year. Then the short sellers will be annoyed
- ·5 t sittenI was wrong when I said I thought Arctic would come with a price target right after Q4, but now I am even more certain that an updated analysis is just around the corner. Why? Because so much fundamentally has strengthened, both in terms of customers, the factory, the annual report running smoothly, a conference in China where one can price in the possibility of partnerships and/or investors willing to pay up for such groundbreaking technology. In the previous analysis, I believe they priced in a lot of risk, in terms of things that could go wrong up until today, and that is certainly the case now.. the only thing missing now is the completed factory, but I believe it's as good as finished, especially when the picture of Jasper Kurth on linkedin is of a specific slide stating that it is on schedule. Then there's DNB's analysis, probably the most conservative analysis on the Oslo Stock Exchange. Yes, it was thoroughly analyzed, but they only emphasized risk, not tax loss carryforward, and minimal value in terms of sales and customers. Personally, I'm guessing a price target of 6.5 from Arctic. What do you think?
- 10 t sitten10 t sittenhttps://www.linkedin.com/posts/thor-medical-asa_cancertreatment-precisionmedicine-radiopharmaceuticals-activity-7444272483211366400-kwT2?utm_source=share&utm_medium=member_ios&rcm=ACoAADUVyGgBbKFcdpxXInSkiOE2XLD9nnPl2WY Back from a good trip to Chengdu, China, and the XDC conference where our CEO, Jasper C. Kurth, presented Thor Medical and the growing interest in lead-212 and our role in the Targeted Alpha Therapy (TAT) landscape. It was great to meet so many talented professionals in the field of radiopharmaceuticals. Thank you for hosting, C-Ray Therapeutics! #CancerTreatment #PrecisionMedicine #Radiopharmaceuticals #AlphaTherapy·8 t sittenIf one looks at one of his slides, it clearly states that completion is on schedule for April. I believe that the most difficult part with the factory is done and that only the finishing touches and machine placements remain now.
- ·10 t sittenFantastic price to buy at for the long-term investor..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 1 155 | - | - | ||
| 1 559 | - | - | ||
| 3 022 | - | - | ||
| 3 719 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
2025 H2 -tulosraportti
32 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 min sittenChoose to interpret it as a good sign; Thor Medical is looking for a Laboratory Engineer/Laboratory Technician https://www.finn.no/457414338
- ·20 min sittenhttps://investorprat.com/TRMED/short The short was increased by 400k more shares, they are now short 2228k shares!·13 min sittenThere might be a rally again soon. A bit early at mechanical completion, but perhaps when news about actual products being sent out to customers. After the common holiday period, that news can come at any time. Then it is reasonable to assume that the share price will go up. Will be very disappointed if the share price only stabilizes around 5kr then. Allowed to hope for a doubling by New Year. Then the short sellers will be annoyed
- ·5 t sittenI was wrong when I said I thought Arctic would come with a price target right after Q4, but now I am even more certain that an updated analysis is just around the corner. Why? Because so much fundamentally has strengthened, both in terms of customers, the factory, the annual report running smoothly, a conference in China where one can price in the possibility of partnerships and/or investors willing to pay up for such groundbreaking technology. In the previous analysis, I believe they priced in a lot of risk, in terms of things that could go wrong up until today, and that is certainly the case now.. the only thing missing now is the completed factory, but I believe it's as good as finished, especially when the picture of Jasper Kurth on linkedin is of a specific slide stating that it is on schedule. Then there's DNB's analysis, probably the most conservative analysis on the Oslo Stock Exchange. Yes, it was thoroughly analyzed, but they only emphasized risk, not tax loss carryforward, and minimal value in terms of sales and customers. Personally, I'm guessing a price target of 6.5 from Arctic. What do you think?
- 10 t sitten10 t sittenhttps://www.linkedin.com/posts/thor-medical-asa_cancertreatment-precisionmedicine-radiopharmaceuticals-activity-7444272483211366400-kwT2?utm_source=share&utm_medium=member_ios&rcm=ACoAADUVyGgBbKFcdpxXInSkiOE2XLD9nnPl2WY Back from a good trip to Chengdu, China, and the XDC conference where our CEO, Jasper C. Kurth, presented Thor Medical and the growing interest in lead-212 and our role in the Targeted Alpha Therapy (TAT) landscape. It was great to meet so many talented professionals in the field of radiopharmaceuticals. Thank you for hosting, C-Ray Therapeutics! #CancerTreatment #PrecisionMedicine #Radiopharmaceuticals #AlphaTherapy·8 t sittenIf one looks at one of his slides, it clearly states that completion is on schedule for April. I believe that the most difficult part with the factory is done and that only the finishing touches and machine placements remain now.
- ·10 t sittenFantastic price to buy at for the long-term investor..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 1 155 | - | - | ||
| 1 559 | - | - | ||
| 3 022 | - | - | ||
| 3 719 | - | - |
Välittäjätilasto
Dataa ei löytynyt